Cohen Yuval — SEC Form 4 filings
SEC reporting owner CIK 1626003. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-30 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 5 filings — 128,996 shares, $3,763,535 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 16,830 shares @ $50.17 ($844,297) in Corbus Pharmaceuticals Holdings, Inc., filed 2024-06-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer, Director | 9 | — | 13 legs · 128,996 sh · $3,763,535 | 26 |
Form 4 filings — Cohen Yuval
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Sale (S): 17,000 @ $10.08 | EDGAR |
| 2026-02-18 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Sale (S): 13,871 @ $7.78 | EDGAR |
| 2026-01-16 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-10-27 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Option exercise (M): 18,660 @ $4.26 · Sale (S): 18,660 @ $17.01 · Option exercise (M): 8,973 @ $4.26 · Sale (S): 8,973 @ $17.14 · Option exercise (M): 18,660 (derivative) @ $0 · Option exercise (M): 8,973 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Sale (S): 7,134 @ $8.76 | EDGAR |
| 2025-02-04 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/award (A): 68,100 @ $0 · Grant/award (A): 228,800 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Option exercise (M): 16,830 @ $14.10 · Sale (S): 16,830 @ $50.17 · Option exercise (M): 12,487 @ $4.26 · Sale (S): 12,487 @ $50.17 · Option exercise (M): 9,333 @ $30 · Sale (S): 9,333 @ $46.02 · +16 more | EDGAR |
| 2024-02-14 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Grant/award (A): 73,947 @ $0 · Grant/award (A): 73,947 (derivative) @ $0 | EDGAR |
| 2024-01-30 | 4 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Option exercise (M): 7,179 @ $4.97 · Option exercise (M): 7,179 (derivative) @ $4.97 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1626003 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →